Search hospitals > Oklahoma > Oklahoma City
Mercy Hospital Oklahoma City
Claim this profileOklahoma City, Oklahoma 73120
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Tumors
238 reported clinical trials
2 medical researchers
Summary
Mercy Hospital Oklahoma City is a medical facility located in Oklahoma City, Oklahoma. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Tumors and other specialties. Mercy Hospital Oklahoma City is involved with conducting 238 clinical trials across 405 conditions. There are 2 research doctors associated with this hospital, such as Jay W Carlson and Terence S. Herman.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
Stage IV
ER positive
Top PIs
Jay W CarlsonMercy Hospital Saint Louis4 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
201 reported clinical trials
281 drugs studied
Terence S. HermanUniversity of Oklahoma Health Sciences Center11 years of reported clinical research
Studies Breast Cancer
1 reported clinical trial
3 drugs studied
Clinical Trials running at Mercy Hospital Oklahoma City
Breast Cancer
Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Bladder Cancer
Bladder Carcinoma
Gastric Cancer
Renal Cell Carcinoma
Squamous Cell Carcinoma
Multiple Myeloma
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Support Program
for Breast Cancer
This phase III trial compares an additional support program (text message reminders and/or telephone-based counseling) with usual care in making sure breast cancer patients take their endocrine therapy medication as prescribed (medication adherence). Medication adherence is how well patients take the medication as prescribed by their doctors, and good medical adherence is when patients take medications correctly. Poor medication adherence has been shown to be a serious barrier to effective treatment for hormone receptor positive breast cancer patients. Adding text message reminders and/or telephone-based counseling to usual care may increase the number of days that patients take their endocrine therapy medication as prescribed.
Recruiting2 awards Phase 34 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Mercy Hospital Oklahoma City?
Mercy Hospital Oklahoma City is a medical facility located in Oklahoma City, Oklahoma. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Tumors and other specialties. Mercy Hospital Oklahoma City is involved with conducting 238 clinical trials across 405 conditions. There are 2 research doctors associated with this hospital, such as Jay W Carlson and Terence S. Herman.